Evidence map›Paper›PMID 27804980›Full record

ArticleScientific reports2016

Novel identified associations of RGS1 and RASGRP1 variants in IgA Nephropathy.

Xu-Jie Zhou, Swapan K Nath, Yuan-Yuan Qi, Celi Sun, Ping Hou, Yue-Miao Zhang, Ji-Cheng Lv, Su-Fang Shi, Li-Jun Liu, Ruoyan Chen and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Xu-Jie ZhouRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Swapan K NathArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Yuan-Yuan QiRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Celi SunArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Ping HouRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Yue-Miao ZhangRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Ji-Cheng LvRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Su-Fang ShiRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Li-Jun LiuRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
Ruoyan ChenDepartment of Paediatrics and Adolescent Medicine Centre for Genomic Sciences, Queen Mary Hospital, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Wanling YangDepartment of Paediatrics and Adolescent Medicine Centre for Genomic Sciences, Queen Mary Hospital, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Kevin Zhi HeDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, USA.
Yanming LiDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, USA.
Hong ZhangRenal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; and Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education; Beijing, 100034, People's Republic of China.
King University · USPeking University · CNOklahoma Medical Research Foundation · USPeking University First Hospital · CNUniversity of Hong Kong · HKQueen Mary Hospital · CNUniversity of Michigan–Ann Arbor · US

Funding

SLE Susceptibility and Clinical Significance at 2q22-24 across Multiple EthnicitiR01AR060366 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2010 to 2019
$3.3M
Health Disparities and Genetic Architecture of Lupus in African AmericansR01MD007909 · NIMHD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2014 to 2018
$2.1M
NIAMS NIH HHS R01 AR060366NIMHD NIH HHS R01 MD007909
6 · The paper itself

Abstract

Known susceptibility loci together can only explain about 6-8% of the disease heritability of IgA nephropathy (IgAN), suggesting that there are still a large number of genetic variants remained to be discovered. We previously identified IgAN and systemic lupus erythematosus (SLE)/lupus nephritis (LN) shared many loci based on GWAS on Chinese populations. The more recent study with high-density genotyping of immune-related loci in individuals with Asian ancestry identified 10 new and 6 suggestive loci in SLE. In the current study, we thus included all the lead SNPs from these 16 loci reported, and firstly tested their associations in 1,248 patients with sporadic IgAN, 737 patients with LN and 1,187 controls. Significant associations identified in IgAN were replicated in additional 500 patients and 2372 controls. rs12022418 in RGS1 (p = 3.0 × 10

Indexed as

AdultAsian PeopleCase-Control StudiesChinaDNA-Binding ProteinsFemaleGenome-Wide Association StudyGenotypeGlomerulonephritis, IGAGuanine Nucleotide Exchange FactorsHumansLupus Erythematosus, SystemicMaleMiddle AgedPolymorphism, Single NucleotideRGS ProteinsDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsRASGRP1 protein, humanRGS1 protein, humanRGS Proteins

Identifiers

PMID27804980
PMCPMC5090199
OpenAlexW2546784200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.